- Home
- ECC vs OCS Comparison
ECC vs OCS Comparison
Compare ECC & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECC
- OCS
- Stock Information
- Founded
- ECC N/A
- OCS 2003
- Country
- ECC United States
- OCS Switzerland
- Employees
- ECC N/A
- OCS N/A
- Industry
- ECC
- OCS Biotechnology: Pharmaceutical Preparations
- Sector
- ECC
- OCS Health Care
- Exchange
- ECC NYSE
- OCS Nasdaq
- Market Cap
- ECC 914.2M
- OCS 916.3M
- IPO Year
- ECC N/A
- OCS N/A
- Fundamental
- Price
- ECC $8.79
- OCS $21.41
- Analyst Decision
- ECC Buy
- OCS Strong Buy
- Analyst Count
- ECC 2
- OCS 5
- Target Price
- ECC $11.00
- OCS $28.80
- AVG Volume (30 Days)
- ECC 679.0K
- OCS 64.5K
- Earning Date
- ECC 02-22-2024
- OCS 03-17-2025
- Dividend Yield
- ECC 19.16%
- OCS N/A
- EPS Growth
- ECC 369.44
- OCS N/A
- EPS
- ECC 1.69
- OCS N/A
- Revenue
- ECC $122,654,279.00
- OCS $1,027,571.00
- Revenue This Year
- ECC $36.58
- OCS $7.98
- Revenue Next Year
- ECC $12.88
- OCS $853.39
- P/E Ratio
- ECC $5.93
- OCS N/A
- Revenue Growth
- ECC 96.41
- OCS N/A
- 52 Week Low
- ECC $8.60
- OCS $10.55
- 52 Week High
- ECC $11.79
- OCS $23.08
- Technical
- Relative Strength Index (RSI)
- ECC 49.28
- OCS 52.07
- Support Level
- ECC $8.69
- OCS $20.95
- Resistance Level
- ECC $8.96
- OCS $21.86
- Average True Range (ATR)
- ECC 0.08
- OCS 0.56
- MACD
- ECC 0.01
- OCS -0.26
- Stochastic Oscillator
- ECC 51.67
- OCS 56.18
About ECC EAGLE POINT CREDIT CO LLC
Eagle Point Credit Co Inc is an externally managed, non-diversified closed-end management investment company.
About OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.